1
Design: Case series study with retrospective analysis of prospectively collected non-randomised data.
2
Methods: This retrospective analysis included 100 patients who underwent elective laparoscopic cholecystectomy.
3
Methods: A retrospective analysis of patients newly diagnosed with CRVO was performed.
4
Materials and methods: We conducted a retrospective analysis of a procedural database.
5
Methods: A retrospective analysis was performed on a prospectively maintained EVAR database.
6
Methods: A retrospective analysis of the multicenter observational TITAN registry was performed.
7
Methods: A retrospective analysis of three prospective randomized NACT trials was performed.
8
In retrospective analysis, there was no survival advantage for patients with GVHD.
9
Of consecutive patients, 1501 with complete data were eligible for retrospective analysis.
10
In a retrospective analysis, we evaluated the complications associated with tumor surgery.
11
A retrospective analysis of a prospective, randomized double-blinded placebo-controlled study was performed.
12
Methods: A retrospective analysis evaluated blood bank versus pharmacy management of PCC.
13
A retrospective analysis was conducted at the Surgery Branch, National Cancer Institute.
14
Methods: This study was a retrospective analysis of a case series.
15
PMID: 26406160 METHODS: A retrospective analysis of operative data was conducted.
16
Methods: We conducted a retrospective analysis of maternity register data from March-September 2016.
